Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - ACELRX PHARMACEUTICALS INC | Financial_Report.xls |
| EX-31.1 - EXHIBIT 31.1 - ACELRX PHARMACEUTICALS INC | ex31-1.htm |
| EX-32.1 - EXHIBIT 32.1 - ACELRX PHARMACEUTICALS INC | ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - ACELRX PHARMACEUTICALS INC | ex31-2.htm |
| EX-10.18 - EXHIBIT 10.18 - ACELRX PHARMACEUTICALS INC | ex10-18.htm |
| 10-K - FORM 10-K - ACELRX PHARMACEUTICALS INC | acrx20141231_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements:
|
(1) |
Registration Statements Form S-8 Nos. 333-194634, 333-187206, 333-180334, 333-172409 pertaining to Employee Incentive Plan of AcelRx Pharmaceuticals, Inc.; |
|
(2) |
Registration Statements Form S-3 Nos. 333-196089, 333-190003, 333-183237, 333-182245 of AcelRx Pharmaceuticals, Inc. and in the related prospectuses; |
|
|
of our reports dated March 12, 2015, with respect to the financial statements of AcelRx Pharmaceuticals, Inc., and the effectiveness of internal control over financial reporting of AcelRx Pharmaceuticals, Inc. included in this Annual Report on Form 10-K of AcelRx Pharmaceuticals, Inc. for the year ended December 31, 2014. |
/s/ Ernst & Young LLP
Redwood City, California
March 12, 2015